6 completed, 1 recruiting. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 6, Recruiting 1 |
Follow Dexmethylphenidate Hydrochloride: new trials by email Literature Review of Dexmethylphenidate Hydrochloride trials Research Report on Dexmethylphenidate Hydrochloride
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH) - Attention Deficit/Hyperactivity Disorder | Phase 4 | Completed | Corium, Inc. | 123 | 2023-06-02 | 2026-05-08 |
| An Efficacy and Safety Study w/ Azstarys® in Children 4-12 Years of Age With ADHD Serdexmethylphenidate (SDX) and dexmethylphenidate (d-MPH), placebo - Attention Deficit/Hyperactivity Disorder | Phase 4 | Completed | Corium, Inc. | 246 | 2023-03-22 | 2025-05-13 |
| Stimulant Effects on Disruptive Behavior Stimulant - Attention Deficit Hyperactivity Disorder, Problem Behavior | Phase 4 | Recruiting | Matthew J O'Brien, PhD, BCBA-D | 10 | 2018-10-01 | 2025-03-17 |
| Omega-3 Supplementation to ADHD Medication in Children Omega-3 Fatty Acid, ADHD Medication - Attention Deficit Hyperactivity Disorder, Deficient Emotional Self-Regulation | Phase 4 | Completed | Massachusetts General Hospital | 21 | 2014-07-01 | 2017-06-29 |
| A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) Dex-methylphenidate hydrochloride extended-release (Focalin XR), Placebo - Attention Deficit Hyperactivity Disorder | Phase 4 | Completed | Novartis Pharmaceuticals | 86 | 2007-10-01 | 2012-04-27 |
| Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder Guanfacine, Methylphenidate (MPH) - Attention Deficit Disorder With Hyperactivity | Phase 4 | Completed | University of California, Los Angeles | 212 | 2007-01-01 | 2021-07-30 |
| Use of Focalin for Fatigue in Sarcoidosis d-methylphenidate - Sarcoidosis | Phase 4 | Completed | University of Cincinnati | 12 | 2006-06-01 | 2011-02-24 |
Attention Deficit Disorder with Hyperactivity (6) · Problem Behavior (1) · Sarcoidosis (1)
Corium, Inc. (2) · Massachusetts General Hospital (1) · Matthew J O'Brien, PhD, BCBA-D (1) · Novartis Pharmaceuticals (1) · University of California, Los Angeles (1) · University of Cincinnati (1)
United States (7)
Ann Childress, MD (2) · James J. McGough, MD (1) · James T. McCracken, MD (1) · Matthew J O'Brien, PhD (1) · Robert P Baughman, MD (1) · Timothy E. Wilens, MD (1)
PMID 18263672, PMID 27453079, PMID 27453080, PMID 27453081, PMID 27483130, PMID 35963558, PMID 35963559, PMID 36971690, PMID 41342306
P50MH077248 (1)